Cantabio Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Cantabio Pharmaceuticals's estimated annual revenue is currently $1.5M per year.
- Cantabio Pharmaceuticals's estimated revenue per employee is $100,500
Employee Data
- Cantabio Pharmaceuticals has 15 Employees.
- Cantabio Pharmaceuticals grew their employee count by 7% last year.
Cantabio Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Head cell biology and in vitro pharmacology | Reveal Email/Phone |
4 | Group Leader, Biochemistry and Biophysics | Reveal Email/Phone |
5 | Associate Consultant | Reveal Email/Phone |
Cantabio Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Cantabio Pharmaceuticals?
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focussing on commercializing novel therapies and the intellectual property generated from our research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases. Our strategy integrates a detailed therapeutic focus, target family biophysics, and drug discovery technology and expertise into an innovative drug discovery approach, which is currently identifying and developing small molecule pharmacological chaperones for clinical trials. In addition, the company is developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins which display loss of function during disease conditions.
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | 7% | N/A |
#2 | $0.5M | 15 | 7% | $300M |
#3 | $1.3M | 15 | -6% | N/A |
#4 | $2.4M | 15 | -67% | N/A |
#5 | $1.3M | 15 | 0% | N/A |